These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 21577086)

  • 61. Prospective and comparative evaluation of the toxicity of adjuvant concurrent chemoradiotherapy after neoadjuvant chemotherapy for breast cancer.
    Marchand V; Angelergues A; Gobaux V; Hajage D; Kirova YM; Campana F; Dendale R; Reyal F; Pierga JY; Fourquet A; Bollet MA
    Am J Clin Oncol; 2013 Oct; 36(5):425-9. PubMed ID: 22706171
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Proton therapy following induction chemotherapy for pediatric and adolescent nasopharyngeal carcinoma.
    Uezono H; Indelicato DJ; Rotondo RL; Sandler ES; Katzenstein HM; Dagan R; Mendenhall WM; Mailhot Vega R; Brennan BM; Bradley JA
    Pediatr Blood Cancer; 2019 Dec; 66(12):e27990. PubMed ID: 31524334
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Radiotherapy concurrently with weekly cisplatin, followed by adjuvant chemotherapy, for N2-3 nasopharyngeal cancer: a multicenter trial of the Forum for Nuclear Cooperation in Asia.
    Ohno T; Thinh DH; Kato S; Devi CR; Tung NT; Thephamongkhol K; Calaguas MJ; Zhou J; Chansilpa Y; Supriana N; Erawati D; Banu PA; Koo CC; Kobayashi K; Nakano T; Tsujii H
    J Radiat Res; 2013 May; 54(3):467-73. PubMed ID: 23192700
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Concurrent chemoradiotherapy with daily low dose intra-arterial cisplatin plus 5-fluorouracil for stage IV nasopharyngeal cancer.
    Kohno N; Ohno Y; Kitahara S; Tamura E; Tanabe T; Murata Y; Kawaida M
    Singapore Med J; 2003 Aug; 44(8):410-3. PubMed ID: 14700420
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The results of nasopharyngeal cancer patients treated by simultaneous integrated boost technique and concomitant chemotherapy.
    Çetindağ MF; Özsavran AY; Yalçın B; Çetindağ İ; Karabekir E; Türkölmez Ş; Yeğen D
    Turk J Med Sci; 2019 Apr; 49(2):558-565. PubMed ID: 30862133
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impact of different therapeutic regimens on survival of patients with nasopharyngeal carcinoma.
    Christodoulopoulos N; Mastronikolis N; Tsiambas E; Jelastopulu E; Spyropoulou D; Lygeros S; Danielides G; Mastronikolis S; A Papadas T
    J BUON; 2019; 24(6):2418-2422. PubMed ID: 31983114
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Alternating chemoradiotherapy in patients with nasopharyngeal cancer: prognostic factors and proposal for individualization of therapy.
    Goto Y; Kodaira T; Fuwa N; Mizoguchi N; Nakahara R; Nomura M; Tomita N; Tachibana H
    J Radiat Res; 2013 Jan; 54(1):98-107. PubMed ID: 22923747
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Addition of Definitive Radiotherapy to Chemotherapy in Patients With Newly Diagnosed Metastatic Nasopharyngeal Cancer.
    Verma V; Allen PK; Simone CB; Gay HA; Lin SH
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1383-1391. PubMed ID: 29118230
    [No Abstract]   [Full Text] [Related]  

  • 69. Preliminary results of a phase I/II study of simultaneous boost irradiation radiotherapy for locally advanced nasopharyngeal carcinoma.
    Xiang L; Wang Y; Xu BQ; Wu JB; Xia YF
    Asian Pac J Cancer Prev; 2013; 14(12):7569-76. PubMed ID: 24460335
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Systemic chemotherapy followed by locoregional definitive intensity-modulated radiation therapy yields prolonged survival in nasopharyngeal carcinoma patients with distant metastasis at initial diagnosis.
    Hu SX; He XH; Dong M; Jia B; Zhou SY; Yang JL; Yang S; Zhang CG; Liu P; Qin Y; Gui L
    Med Oncol; 2015 Sep; 32(9):224. PubMed ID: 26219572
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Optimizing the treatment mode for de novo metastatic nasopharyngeal carcinoma with bone-only metastasis.
    Lin C; Lin S; Zhu L; Lin S; Pan J; Xu Y
    BMC Cancer; 2022 Jan; 22(1):35. PubMed ID: 34983459
    [TBL] [Abstract][Full Text] [Related]  

  • 72. M1 stage subdivision and treatment outcome of patients with bone-only metastasis of nasopharyngeal carcinoma.
    Shen L; Dong J; Li S; Wang Y; Dong A; Shu W; Wu M; Pan C; Xia Y; Wu P
    Oncologist; 2015 Mar; 20(3):291-8. PubMed ID: 25660157
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of cytokeratin-19 mRNA as a tumor marker in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.
    Lin JC; Chen KY; Wang WY; Jan JS; Liang WM; Wei YH
    Int J Cancer; 2002 Feb; 97(4):548-53. PubMed ID: 11802221
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In regard to Cheng et al., examining prognostic factors of failure in nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy: impact on future clinical trials. IJROBP 2001;50:717-726.
    Cengiz M; Ozyar E; Atahan IL
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1144; author reply 1144-5. PubMed ID: 11958916
    [No Abstract]   [Full Text] [Related]  

  • 75. [Metastatic nasopharynx cancer at diagnosis: clinical and prognostic (study of 51 cases)].
    Bouaouina N; Ouni S; Kanoun SB; Neffeti AB; Kermani W; Abdelkefi M
    Pan Afr Med J; 2018; 29():155. PubMed ID: 30050619
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Long-term efficacy of microwave hyperthermia combined with chemoradiotherapy in treatment of nasopharyngeal carcinoma with cervical lymph node metastases.
    Kang M; Liu WQ; Qin YT; Wei ZX; Wang RS
    Asian Pac J Cancer Prev; 2013; 14(12):7395-400. PubMed ID: 24460309
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Therapeutic Effect of Chemotherapy Cycle in Nasopharyngeal Carcinoma (NPC) Patients Who Developed Bone-Only Metastasis.
    Nong S; Pan X; Chen K; Li Y; Zhu X
    Med Sci Monit; 2020 Jun; 26():e922244. PubMed ID: 32541642
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Descriptive Study of Nasopharyngeal Carcinoma and Treatment Outcomes: An Eight Years Experience in Hadhramout National Cancer Centre, Yemen.
    Bahannan AA; Badheeb AM; Baothman SY
    Gulf J Oncolog; 2019 May; 1(30):61-66. PubMed ID: 31242984
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Development of a ten-signature classifier using a support vector machine integrated approach to subdivide the M1 stage into M1a and M1b stages of nasopharyngeal carcinoma with synchronous metastases to better predict patients' survival.
    Jiang R; You R; Pei XQ; Zou X; Zhang MX; Wang TM; Sun R; Luo DH; Huang PY; Chen QY; Hua YJ; Tang LQ; Guo L; Mo HY; Qian CN; Mai HQ; Hong MH; Cai HM; Chen MY
    Oncotarget; 2016 Jan; 7(3):3645-57. PubMed ID: 26636646
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis.
    Chen MY; Jiang R; Guo L; Zou X; Liu Q; Sun R; Qiu F; Xia ZJ; Huang HQ; Zhang L; Hong MH; Mai HQ; Qian CN
    Chin J Cancer; 2013 Nov; 32(11):604-13. PubMed ID: 24206918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.